142 related articles for article (PubMed ID: 10449674)
1. Transforming growth factor alpha (TGF-alpha) expression in dysplastic oral leukoplakia: modulation by 13-cis retinoic acid.
Beenken SW; Sellers MT; Huang P; Peters G; Krontiras H; Dixon P; Stockard C; Listinsky C; Grizzle WE
Head Neck; 1999 Sep; 21(6):566-73. PubMed ID: 10449674
[TBL] [Abstract][Full Text] [Related]
2. Retinoid modulation of biomarkers in oral leukoplakia/dysplasia.
Beenken SW; Huang P; Sellers M; Peters G; Listinsky C; Stockard C; Hubbard W; Wheeler R; Grizzle W
J Cell Biochem Suppl; 1994; 19():270-7. PubMed ID: 7823600
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-alpha: a surrogate endpoint biomarker?
Beenken SW; Hockett R; Grizzle W; Weiss HL; Pickens A; Perloff M; Malone WF; Bland KI
J Am Coll Surg; 2002 Aug; 195(2):149-58. PubMed ID: 12168960
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-alpha overexpression in proliferative verrucous leukoplakia and oral squamous cell carcinoma: an immunohistochemical study.
Kannan R; Bijur GN; Mallery SR; Beck FM; Sabourin CL; Jewell SD; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Jul; 82(1):69-74. PubMed ID: 8843456
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry.
Srinivasan M; Jewell SD
Oncology; 2001; 61(4):284-92. PubMed ID: 11721175
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias.
Prado SM; Cedrún JL; Rey RL; Villaamil VM; García AA; Ayerbes MV; Aparicio LA
Exp Mol Pathol; 2010 Oct; 89(2):197-203. PubMed ID: 20599939
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-Myc, TGF-alpha and EGF-receptor in sporadic medullary thyroid carcinoma.
Wang W; Johansson HE; Bergholm UI; Westermark KM; Grimelius LE
Acta Oncol; 1997; 36(4):407-11. PubMed ID: 9247102
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines.
Rubin Grandis J; Zeng Q; Tweardy DJ
Nat Med; 1996 Feb; 2(2):237-40. PubMed ID: 8574972
[TBL] [Abstract][Full Text] [Related]
10. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the clinical and histological effectiveness of isotretinoin in the therapy of oral leukoplakia: ten years of experience: is management still up to date and effective?
Scardina GA; Carini F; Maresi E; Valenza V; Messina P
Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):115-9. PubMed ID: 16636722
[TBL] [Abstract][Full Text] [Related]
12. AgNOR count as objective marker for dysplastic features in oral leukoplakia.
Chattopadhyay A; Ray JG; Caplan DJ
J Oral Pathol Med; 2002 Oct; 31(9):512-7. PubMed ID: 12269989
[TBL] [Abstract][Full Text] [Related]
13. Topical oral cavity chemoprophylaxis using isotretinoin rinse: A 15-year experience.
Kadakia S; Badhey A; Milam M; Lee T; Ducic Y
Laryngoscope; 2017 Jul; 127(7):1595-1599. PubMed ID: 28000225
[TBL] [Abstract][Full Text] [Related]
14. Expression of retinoic acid receptors in normal, dysplastic and malignant oral epithelia.
Sherman JA; Partridge M
Br J Oral Maxillofac Surg; 1997 Aug; 35(4):260-6. PubMed ID: 9291264
[TBL] [Abstract][Full Text] [Related]
15. Cellular sources of transforming growth factor-alpha in human oral cancer.
Todd R; Chou MY; Matossian K; Gallagher GT; Donoff RB; Wong DT
J Dent Res; 1991 May; 70(5):917-23. PubMed ID: 2022775
[TBL] [Abstract][Full Text] [Related]
16. Chewing tobacco may act as a risk factor for dysplastic transformation of squamous cells in Oral leukoplakia- A cytochemistry based approach.
Bhattacharyya S; Ray S; Saha D; Mustafi SM; Alam N; Sarkar A; Murmu N
Pathol Res Pract; 2021 Feb; 218():153287. PubMed ID: 33454586
[TBL] [Abstract][Full Text] [Related]
17. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
[TBL] [Abstract][Full Text] [Related]
18. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma.
Rubin Grandis J; Tweardy DJ; Melhem MF
Clin Cancer Res; 1998 Jan; 4(1):13-20. PubMed ID: 9516947
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
Gupta K; Metgud R; Gupta J
J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
[TBL] [Abstract][Full Text] [Related]
20. Silver-binding nucleolar organizing regions: a study of oral leukoplakia and squamous cell carcinoma.
Chattopadhyay A; Chawda JG; Doshi JJ
Int J Oral Maxillofac Surg; 1994 Dec; 23(6 Pt 1):374-7. PubMed ID: 7699280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
